Advances in structural heart repair/replacement, cardiac rhythm management, interventional techniques, cell replacement and regeneration therapies continue to refine one of the most successful areas of modern medicine: cardiac care.
A new study by Abbott Laboratories found that their drug-coated stent, Xience V, is more effective in the long term than a competitor’s. According to the Wall Street Journal, the data showed that rates of major cardiovascular events plateaued at 6.4% in the second and third years after Xience was implanted.
Copyright © 2024 | WordPress Theme by MH Themes